Company Filing History:
Years Active: 2004-2013
Title: Akinori Kume: Innovator in Lactic Acid Bacteria and Immunotherapy
Introduction
Akinori Kume is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the fields of dietary products and pharmaceuticals through his innovative research. With a total of 3 patents, Kume's work focuses on the development of lactic acid bacteria and peptide-based immunotherapeutic agents.
Latest Patents
One of Kume's latest patents is for a lactic acid bacterium that has the effect of lowering blood uric acid levels. This invention provides lactic acid bacteria suitable for dietary products and pharmaceuticals, which can suppress the increase of blood uric acid levels. Various types of lactic acid bacteria were cultured in the presence of purines, leading to the selection of several strains with remarkable purine-decomposing abilities. Among these, the strain OLL2922 was found to significantly suppress serum uric acid levels in rats.
Another significant patent is a peptide-based immunotherapeutic agent effective for allergy patients. This agent allows for the optimal peptide-based immunotherapy tailored to individual patients. It also includes a reagent for typing HLA class II molecules, facilitating the selection of effective therapeutic agents for allergy patients. This innovation is particularly beneficial for patients who cannot be treated with conventional peptide-based immunotherapy.
Career Highlights
Kume has worked with prominent companies such as Meiji Milk Products Company, Limited and Meiji Dairies Corporation. His experience in these organizations has contributed to his expertise in the development of innovative health solutions.
Collaborations
Some of Kume's notable coworkers include Toshio Sone and Kazuo Dairiki. Their collaborative efforts have likely played a role in advancing Kume's research and inventions.
Conclusion
Akinori Kume's contributions to the fields of lactic acid bacteria and immunotherapy highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to scientific advancement and the betterment of patient care.